These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 1324584

  • 1. Partial agonists of benzodiazepine receptors for the treatment of epilepsy, sleep, and anxiety disorders.
    Haefely W, Facklam M, Schoch P, Martin JR, Bonetti EP, Moreau JL, Jenck F, Richards JG.
    Adv Biochem Psychopharmacol; 1992; 47():379-94. PubMed ID: 1324584
    [Abstract] [Full Text] [Related]

  • 2. Relationship between benzodiazepine receptor occupancy and functional effects in vivo of four ligands of differing intrinsic efficacies.
    Facklam M, Schoch P, Bonetti EP, Jenck F, Martin JR, Moreau JL, Haefely WE.
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1113-21. PubMed ID: 1318371
    [Abstract] [Full Text] [Related]

  • 3. Aspects of benzodiazepine receptor structure and function with relevance to drug tolerance and dependence.
    Schoch P, Moreau JL, Martin JR, Haefely WE.
    Biochem Soc Symp; 1993 Jun; 59():121-34. PubMed ID: 7910739
    [Abstract] [Full Text] [Related]

  • 4. [Pharmacotherapy with benzodiazepines: basic principles and new developments].
    Möhler H.
    Praxis (Bern 1994); 1998 Feb 04; 87(6):186-90. PubMed ID: 9531812
    [Abstract] [Full Text] [Related]

  • 5. Anticonvulsant efficacy of the low-affinity partial benzodiazepine receptor agonist ELB 138 in a dog seizure model and in epileptic dogs with spontaneously recurrent seizures.
    Löscher W, Potschka H, Rieck S, Tipold A, Rundfeldt C.
    Epilepsia; 2004 Oct 04; 45(10):1228-39. PubMed ID: 15461677
    [Abstract] [Full Text] [Related]

  • 6. The multiplicity of actions of benzodiazepine receptor ligands.
    Haefely WE, Martin JR, Richards JG, Schoch P.
    Can J Psychiatry; 1993 Nov 04; 38 Suppl 4():S102-8. PubMed ID: 8306240
    [Abstract] [Full Text] [Related]

  • 7. [GABA(A) benzodiazepine receptors and epilepsy].
    Sieghart W.
    Wien Klin Wochenschr; 1990 Mar 30; 102(7):197-201. PubMed ID: 2160756
    [Abstract] [Full Text] [Related]

  • 8. RP 59037 and RP 60503: anxiolytic cyclopyrrolone derivatives with low sedative potential. interaction with the gamma-aminobutyric acidA/benzodiazepine receptor complex and behavioral effects in the rodent.
    Doble A, Canton T, Dreisler S, Piot O, Boireau A, Stutzmann JM, Bardone MC, Rataud J, Roux M, Roussel G.
    J Pharmacol Exp Ther; 1993 Sep 30; 266(3):1213-26. PubMed ID: 8103792
    [Abstract] [Full Text] [Related]

  • 9. [Better cure for anxiety, sleep disorders, epilepsy?].
    Korpi ER, Wisden W, Lüddens H.
    Lakartidningen; 1997 Sep 24; 94(39):3403-8. PubMed ID: 9379810
    [Abstract] [Full Text] [Related]

  • 10. Future directions in anxiolytic pharmacotherapy.
    Kunovac JL, Stahl SM.
    Psychiatr Clin North Am; 1995 Dec 24; 18(4):895-909. PubMed ID: 8748388
    [Abstract] [Full Text] [Related]

  • 11. Imidazenil: a new partial positive allosteric modulator of gamma-aminobutyric acid (GABA) action at GABAA receptors.
    Giusti P, Ducić I, Puia G, Arban R, Walser A, Guidotti A, Costa E.
    J Pharmacol Exp Ther; 1993 Aug 24; 266(2):1018-28. PubMed ID: 8394902
    [Abstract] [Full Text] [Related]

  • 12. NS11394 [3'-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile], a unique subtype-selective GABAA receptor positive allosteric modulator: in vitro actions, pharmacokinetic properties and in vivo anxiolytic efficacy.
    Mirza NR, Larsen JS, Mathiasen C, Jacobsen TA, Munro G, Erichsen HK, Nielsen AN, Troelsen KB, Nielsen EØ, Ahring PK.
    J Pharmacol Exp Ther; 2008 Dec 24; 327(3):954-68. PubMed ID: 18791063
    [Abstract] [Full Text] [Related]

  • 13. Ro 19-8022, a nonbenzodiazepine partial agonist at benzodiazepine receptors: neuropharmacological profile of a potential anxiolytic.
    Jenck F, Moreau JL, Bonetti EP, Martin JR, Haefely WE.
    J Pharmacol Exp Ther; 1992 Sep 24; 262(3):1121-7. PubMed ID: 1356150
    [Abstract] [Full Text] [Related]

  • 14. [The benzodiazepine receptor: the enigma of the endogenous ligand].
    Pélissolo A.
    Encephale; 1995 Sep 24; 21(2):133-40. PubMed ID: 7781584
    [Abstract] [Full Text] [Related]

  • 15. Pharmacology of the human gamma-aminobutyric acidA receptor alpha 4 subunit expressed in Xenopus laevis oocytes.
    Whittemore ER, Yang W, Drewe JA, Woodward RM.
    Mol Pharmacol; 1996 Nov 24; 50(5):1364-75. PubMed ID: 8913369
    [Abstract] [Full Text] [Related]

  • 16. Behavioral and biochemical characterization of benzodiazepine receptor partial agonists in pigeons.
    Witkin JM, Acri JB, Wong G, Gleeson S, Barrett JE.
    J Pharmacol Exp Ther; 1996 Apr 24; 277(1):87-96. PubMed ID: 8613971
    [Abstract] [Full Text] [Related]

  • 17. Pharmacology of tolerance to benzodiazepine receptor ligands.
    Płaźnik A.
    Pol J Pharmacol; 1995 Apr 24; 47(6):489-99. PubMed ID: 8868371
    [Abstract] [Full Text] [Related]

  • 18. Anticonvulsant tolerance and withdrawal characteristics of benzodiazepine receptor ligands in different seizure models in mice. Comparison of diazepam, bretazenil and abecarnil.
    Rundfeldt C, Wlaź P, Hönack D, Löscher W.
    J Pharmacol Exp Ther; 1995 Nov 24; 275(2):693-702. PubMed ID: 7473156
    [Abstract] [Full Text] [Related]

  • 19. GABA(A) agonists and partial agonists: THIP (Gaboxadol) as a non-opioid analgesic and a novel type of hypnotic.
    Krogsgaard-Larsen P, Frølund B, Liljefors T, Ebert B.
    Biochem Pharmacol; 2004 Oct 15; 68(8):1573-80. PubMed ID: 15451401
    [Abstract] [Full Text] [Related]

  • 20. Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects.
    Depoortere H, Zivkovic B, Lloyd KG, Sanger DJ, Perrault G, Langer SZ, Bartholini G.
    J Pharmacol Exp Ther; 1986 May 15; 237(2):649-58. PubMed ID: 2871178
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.